A new study called COVID-OUT, carried out by researchers from the University of Minnesota, found that metformin, a safe, inexpensive and widely available drug commonly used to treat diabetes, prevents the development of Long COVID.
The results of this study have just been published in The Lancet Infectious Diseases.
Study shows metformin lowers the risk of getting long COVID (worldpharmanews.com)
Full article available here: Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial – The Lancet Infectious Diseases
